Evaxion A (EVAX) Non-Current Assets (2019 - 2025)
Evaxion A (EVAX) reported Non-Current Assets of $3.5 million for Q4 2025, down 5.73% on a YoY basis from $3.7 million in Q4 2024, and down 17.91% quarter-over-quarter from $4.3 million in Q2 2025.
Evaxion A (EVAX) Non-Current Assets (2019 - 2025) Analysis & Trends
Evaxion A has reported Non-Current Assets for 7 years, with the latest figure at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets fell 5.73% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 5.73% YoY), and the FY2025 full-year result was $3.5 million, down 5.73% from the prior year.
- Non-Current Assets for Q4 2025 stood at $3.5 million, down from $4.3 million in the prior quarter.
- The five-year high for Non-Current Assets was $7.8 million in Q3 2021, with the low at $2.4 million in Q1 2021.
- Historically, Non-Current Assets has averaged $4.8 million across 5 years, with a median of $4.5 million in 2023.
- Annual changes were most pronounced in 2021 — Non-Current Assets jumped 437.73% — and 2024, when it retreated 18.04%.
- Evaxion A's Non-Current Assets stood at $5.5 million in 2021, then declined by 7.66% to $5.0 million in 2022, then retreated by 9.94% to $4.5 million in 2023, then dropped by 18.04% to $3.7 million in 2024, then fell by 5.73% to $3.5 million in 2025.
- The last three Non-Current Assets figures came in at $3.5 million (Q4 2025), $4.3 million (Q2 2025), and $3.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 22.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.51 Mn |
| Jun 30, 2025 | 4.27 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Dec 31, 2022 | 5.04 Mn |
| Jun 30, 2022 | 5.48 Mn |
| Mar 31, 2022 | 5.70 Mn |
| Dec 31, 2021 | 5.46 Mn |
| Sep 30, 2021 | 7.80 Mn |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 2.43 Mn |
| Dec 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 126,000.00 |